Drugs / Omeza® Complete Matrix
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05921292 | Jul 2022 → Jan 2024 | chronic ulcer of skin | Omeza, LLC | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Omeza Complete Matrix | “Omeza® Complete Matrix (OCM™)” NCT05921292 ↗ |
| Known as | OCM | “Omeza® Complete Matrix (OCM™)” NCT05921292 ↗ |
| Route | Topical | “OCM™ will be applied directly to the wound/ulcer” NCT05921292 ↗ |